These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33025622)

  • 1. Identification of peripheral CD154
    Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
    Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
    J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
    Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor repertoires within liver allografts are different to those in the peripheral blood.
    Mederacke YS; Nienen M; Jarek M; Geffers R; Hupa-Breier K; Babel N; Reinke P; Mederacke I; Vondran FWR; Jonigk D; Wedemeyer H; Jaeckel E
    J Hepatol; 2021 May; 74(5):1167-1175. PubMed ID: 33347951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation.
    Ashokkumar C; Shapiro R; Tan H; Ningappa M; Elinoff B; Fedorek S; Sun Q; Higgs BW; Randhawa P; Humar A; Sindhi R
    Transplantation; 2011 Aug; 92(4):433-8. PubMed ID: 21747326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection.
    Creemers P; Brink J; Wainwright H; Moore K; Shephard E; Kahn D
    Transpl Immunol; 2002 Nov; 10(4):285-92. PubMed ID: 12507400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
    Ashokkumar C; Gupta A; Sun Q; Ningappa MB; Higgs BW; Mazariegos G; Fazzolare T; Remaley L; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
    Surgery; 2009 Aug; 146(2):166-73. PubMed ID: 19628070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the participation of different T cell subsets in rat liver allograft rejection. Comparison of liver with heart graft.
    Sumimoto R; Kimura H; Yamaguchi A; Kamada N
    Transpl Int; 1992; 5 Suppl 1():S636-8. PubMed ID: 14621896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
    J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Expression of Activated CD8
    Boix F; Jimenez-Coll V; Legaz I; Alfaro R; Moya-Quiles MR; Peña-Moral J; Minguela A; Llorente S; Muro M
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):119. PubMed ID: 37395036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of functionally distinct T-lymphocyte subsets in heart transplant recipients after induction therapy with anti-CD25 monoclonal antibodies.
    Lanio N; Sarmiento E; Gallego A; Navarro J; Palomo J; Fernandez-Yañez J; Ruiz M; Fernandez-Cruz E; Carbone J
    Transpl Immunol; 2013 Jun; 28(4):176-82. PubMed ID: 23611763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.
    Boix F; Millan O; San Segundo D; Mancebo E; Rimola A; Fabrega E; Fortuna V; Mrowiec A; Castro-Panete MJ; Peña Jde L; Llorente S; Minguela A; Bolarin JM; Paz-Artal E; Lopez-Hoyos M; Brunet M; Muro M
    Immunobiology; 2016 May; 221(5):595-603. PubMed ID: 26850323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome.
    Bartlett A; McCall J; Ameratunga R; Munn S
    Clin Transplant; 2000 Dec; 14(6):520-8. PubMed ID: 11127303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.